Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.
Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.
The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.
The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.
To find out whether a product is currently authorised for supply in Australia, check the ARTG.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medicine suspension (74)
- Medical device cancellation (63)
- Medical device cancellation - certain devices within an entry (9)
- Voluntary revocation at the request of the manufacturer (9)
- Revocation of a TGA issued Conformity Assessment Certificate (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- Alphapharm Pty Ltd (1)
- Complementary medicine cancellation (1)
- Medical device cancellation (1)
- Medical device suspension (1)
- Medicine cancellation (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
Find out more about Cancellations and Suspensions.
Search
191 result(s) found, displaying 1 to 25
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to , effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2024
-
Cancellation or suspensionCancellation of the entry as the sponsor did not provide information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a).
-
Cancellation or suspensionCancellation of the entry as the sponsor did not provide information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a).
-
Cancellation or suspensionCancellation of the entry as the sponsor did not provide information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a).
-
Cancellation or suspensionCancellation of the entry as the sponsor did not provide information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a).
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 19/11/2024
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 2/09/2024
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 29/10/2024
-
Cancellation or suspensionCancellation of the entry as the sponsor has refused or failed to comply with a condition to which the inclusion of the goods is subject (paragraph 30(2)(c) of the Act).
-
Cancellation or suspensionCancellation of the entry due to the sponsor not providing sufficient information to substantiate compliance with the Essential Principles.
-
Cancellation or suspensionCancellation of the entry due to the sponsor not providing sufficient information to substantiate compliance with the Essential Principles.
-
Cancellation or suspensionCancellation of the entry due to incorrect classification of the device.
-
Cancellation or suspensionCancellation from the ARTG under subsection 41GN(1)(b) of the Act
-
Cancellation or suspensionCancellation from the ARTG under subsection 41GN(1) of the Act. Cancellation is limited to some medical devices of the kind and the ARTG is varied accordingly under section 41GO of the Act.
-
Cancellation or suspensionCancellation from the ARTG under subsection 41GN(1) of the Act.
Last updated